BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Wlcus - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Wlcus
X-ORIGINAL-URL:https://wlcus.com
X-WR-CALDESC:Events for Wlcus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230830T080000
DTEND;TZID=UTC:20230831T170000
DTSTAMP:20241227T183511Z
CREATED:20240729T141616Z
LAST-MODIFIED:20241227T183511Z
UID:6685-1693382400-1693501200@wlcus.com
SUMMARY:Clinical Project Management To Advance Your Clinical Programs Master class\, Online 30-31 August 2023
DESCRIPTION:INTRODUCTION:\nDuring these 2 Days’ of online sessions\, Trainees will learn how to adapt their project management knowledge to clinical trials. They will see how to manage clinical trials\, set milestones\, do risk management\, allocate staff and budgets\, dealing with clients and contracts. Several components of successful project management such as the inte-raction between project activities and key decisions will be highlighted. This is a very interactive course with workshops\, putting the theoretical concepts into practice. \nKEY TAKEAWAYS:\n• What are the fundamentals of Project Management? Which Project Management Techniques exit?\n• The Project Manager (negotiation\, delegation\, dealing with clients\, quality)\n• The Project Environment (regulations\, guidelines\, SOPs)\n• Clinical Trial life cycle\n• The clinical development Plan\n• CRO selection basics\n• The definition and initiation of a Trial (scope\, feasibility\, CDP)\n• The planning of the Trial (project plan\, milestones\, schedules\, charts\, risk management\, contracts)\n• The Project Budget (budget sheets\, budget control)\n• The execution of the Trial (monitoring and controlling\, reporting\, dealing with changes)\n• How to manage a clinical operation team\n• The closure of the Trial (archiving\, evaluation\, project failure reasons) \nRECOMMENDATION:\nWho can attend?\n\nProject managers (or related clinical research professionals) who have just entered the world of\nproject management in clinical research.\nSenior Clinical Research Associates (CRAs)\nPeople who are interacting regularly with Project Managers and who want to understand the\npitfalls of clinical project management.\n\nTRAINER:\n \nNELLE STOCQUART \nClinical Operation expert and trainer at Solutionelle. Experienced Project Manager and Instructor with a demonstrated history of working in the professional training & pharmaceutical industry. Skilled in Vaccines\, Training Delivery\, Software Documentation\, CRO Management\, Clinical Project Management\, Risk Management\, Risk Based Monitoring and Oncology Clinical Research. \nWith a master’s in chemistry Nelle Stocquart works since 2003 in the Clinical Research world. She was first an IVRS project manager for a Belgian CRO but then she wished gaining more experience on the field and became CRA for a top 5 international CRO where she got involved in many international phases II & III from early study stage till closure. She then evolved as project manager in pharmaceutical companies and CRO where she managed local and international studies from phase I to phase IV. She is now working for the Belgian government which is funding academic studies. Nelle has a lot of experience in project management\, team management and people coaching. Training\, Coaching\, Education and Continuous Professional Development have always been the common pillars in her educational path and professional career. She speaks fluently 3 languages (Dutch\, French and English).
URL:https://wlcus.com/event/clinical-project-management-to-advance-your-clinical-programs-master-class-online-30-31-august-2023/
LOCATION:Online
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/d78f0d1185b00af14b059380.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240515T080000
DTEND;TZID=UTC:20240516T170000
DTSTAMP:20241227T183434Z
CREATED:20240731T102743Z
LAST-MODIFIED:20241227T183434Z
UID:6797-1715760000-1715878800@wlcus.com
SUMMARY:Pharmacovigilance 2024: Mastering Benefit-Risk Excellence Masterclass\, Online 15-16 May 2024
DESCRIPTION:INTRODUCTION:\nWelcome to the “Benefit-Risk Assessment in Pharmacovigilance Master Class 2024”\, A comprehensive two-day training designed to provide in-depth insights into the latest trends and methodologies shaping benefit-risk assessment within the pharmaceutical industry. This masterclass aims to equip participants with the essential knowledge and practical skills needed to navigate the complexities of benefit-risk evaluation throughout the lifecycle of medicinal products. \nKEY BENEFITS:\nBy participating in this masterclass\, attendees will gain a thorough understanding of benefit-risk frameworks\, methodologies\, and regulatory expectations. The training offers a unique opportunity to enhance proficiency in performing hands-on benefit-risk analyses\, ensuring participants are well-prepared to critically evaluate results and make informed decisions. Whether you are involved in drug safety\, pharmacovigilance\, regulatory affairs\, or clinical research\, this masterclass will empower you to optimize\nbenefit-risk balance. \nWHO SHOULD ATTEND:\n● Drug safety and pharmacovigilance professionals\n● Safety evaluation experts\n● Professionals involved in periodic safety reporting\n● Experts in risk management planning and development of formal Risk Management Plans/REMS\n● Medical writers.\n● Regulatory strategy and regulatory affairs professionals.\n● Clinical research experts.\n● Medical Affairs professionals.
URL:https://wlcus.com/event/pharmacovigilance-2024-mastering-benefit-risk-excellence-masterclass-online-15-16-may-2024/
LOCATION:Online
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/8e2dab24887da23b9f4fbd8e.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250515T083000
DTEND;TZID=UTC:20250516T163000
DTSTAMP:20251116T205734Z
CREATED:20240505T052417Z
LAST-MODIFIED:20251116T205734Z
UID:7959-1747297800-1747413000@wlcus.com
SUMMARY:IMMUNOIMPACT: Immunogenicity Insights & Strategies Masterclass 2025
DESCRIPTION:Register Now !\nIMMUNOIMPACT: Immunogenicity Insights & Strategies Masterclass 2025\nIntroduction:\nWelcome to the IMMUNOIMPACT: Immunogenicity Insights & Strategies Masterclass 2025\, an intensive and informative workshop designed to explore the complexities of immunogenicity while ensuring compliance with the European Medicines Agency's (EMA) guidelines. Over two days\, we will examine key concepts\, methodologies\, and practical approaches to understanding and managing immunogenicity in the context of therapeutic interventions.\nKey Takeaways:\nParticipants will gain insights into the following topics:Immunogenicity and Antigenicity.Generation and management of Anti-Drug Antibodies (ADAs) in immunogenicity.Clinical configurations and procedures for monitoring immunogenicity.Utilization of animal data to navigate clinical challenges.Development of diagnostic tools and technologies.Role of drugs in combating serious adverse events.Advanced bioinformatics and procedure verification.Product evolution and addressing complexities.Immunogenicity surveillance in pharmacovigilance.Analysis of safety approaches.Assay methods for ADA quantification.Regulatory compliance in alignment with EMA guidelines.\nWho Should Attend?\nImmunologist\nClinical Research Scientist\nRegulatory Affairs Specialist\nPharmaceutical Scientist\nDrug Safety Officer\nDetails:\nLocation / Venue: Online / Virtual\nTrainer: TBA\nDate: 15th-16th\, May 2025\nOrganizer: Wlcus\nRegister Now!\nUpcoming Events\nPharma Summit 2025
URL:https://wlcus.com/event/immunogenicity-masterclass-2025-pharma-biotech-insights/
LOCATION:Online
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/672e6eed0056729547afee06.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251015T080000
DTEND;TZID=UTC:20251016T170000
DTSTAMP:20251116T205805Z
CREATED:20241119T113038Z
LAST-MODIFIED:20251116T205805Z
UID:9463-1760515200-1760634000@wlcus.com
SUMMARY:GLOBAL RWE AND MARKET ACCESS SUMMIT 2025
DESCRIPTION:Request Agenda\nRegister Now\nKey Benefits\nwhat makes us different\nValuable Skills\nGain essential knowledge and practical skills needed to effectively oversee and improve health and safety protocols in your work environment\nNetworking\nConnect with other professionals in the field to share insights\, discuss best practices\, and build a supportive community\nCertification\nEarn an official certification that validates your expertise and successful completion of the health and safety conference\nCompetitive edge\nEnhance your resume with specialized health and safety skills\, making you a more attractive candidate for employers and boosting your business credentials\nBoost Confidence\nDevelop the confidence to effectively manage health and safety responsibilities\, ensuring a safer workplace for all\nOpportunities\nGet Collaboration and Professional opportunities from Well established Professionals in different Sectors\nFollowing are joining the Summit on October 15th - 16th in Frankfurt\, Germany.\nPharmaceutical Companies\nBio-Pharma Companies\nChief Executives\nVice Presidents\nDirectors\nGlobal Heads & Leaders\nSenior Managers\nResearcher & Analysts\nInvestigators & Scientists\nReal World Data-\nReal World Evidence - RWE\nHEOR\nData Analytics\nMarket Access / Value Access\nClinical Development & Research\nClinical Trial\nEpidemiology\nOncology - RWE\nMedical Affairs\nPharmacovigilance\nBig Data / Data Science\nBio Statistics\nConsumer Healthcare\nGlobal RWE & Market Access Summit 2025\, Stats:\nSpeakers\nProfessionals & Leaders\nCountries\nMeet the Pioneers\nOur Prestigious Panel of Speakers\nAneta Tyszkiewicz\nDirectorData and Digital\nEuropean Federation of Pharmaceutical Industries and Associations - (EFPIA)\nSandeep Kiri\nGlobal Head of Health Economics\nU C B\nOmar Ali\nFormer Adviser to NICE\,  Head of Payers\nVerpora\nArup Pramanik\nCorporate Vice President\,  Global Market Access\nBoehringer Ingelheim\nAlexandros Sagkriotis\nIndependent RWE Strategist & \nThought Leader\nAlexandros Sagkriotis Consultants\nFabrizio Gianfrate\nFull Professor of  Health Economics\nUniversity of Rome\nDr. Magda Chatzikou\nHTA & RWE Strategist of Digital Health\nPharmecons Easy Access\nDr. Sascha van Boemmel\nSenior Manager Scientific Engagement\nFlatiron Health\nIgnacio H. Medrano\nChief Medical Officer & \nFounder\nSavana\nGalina Osina\nReal World Evidence \nStrategic Lead\, MD\nEx-Roche\nDr. Shikta Das\nReal World Evidence \nScientific Lead\nAstraZeneca\nFrancesca Frau\, PhD\nDevelopment Real World Evidence Lead\nSanofi\nDr. Hans-Jürgen Arens\nVice President \nGlobal Data Analytics Services\nFrenova\nCristina Masseria PhD.\, MSc.\nVice President \nEurope Strategic Partnerships\nAesara\nAndrea Parodi\nHead of Biostatistics\nValos\nMartin Rost\nVice President Value &  Evidence Team Lead\nAesara\nKate Burslem\nValue & Evidence EU Team Lead\nAesara\nKemal Uca\nVP Head of Global Value Demonstration\, Access & Pricing\, CM&E and Fertility\nMerck Healthcare\nNoolie Gregory\nHead of Evidence Generation\nSciensus\nAndrew Cummins\nVice President\,\nBusiness Development\nSciensus\nDr. Thomas Ecker\nCEO & Lead EU HTA\nEcker + Ecker\nNooten Foortje Van\nHead of EU Market Access\nShionogi\nFeaturing Sponsors & Partners\nFlatiron\nAESARA\nSciensus\nSavana\nGold Sponsor\nFlatiron Health is an innovative healthcare technology company and a leader in real-world evidence (RWE) in oncology. For over 10 years\, we have pioneered data-driven solutions\, transforming patients experiences into clinically meaningful\, longitudinal RWE. The results of our work are the basis of over 550 high-impact scientific publications and have been successfully submitted to health authorities in the US\, Europe and Asia.\nGold Sponsor\nAESARA is a boutique\, digitally forward Value & Access agency dedicated to revolutionizing patient access and product value within the life sciences industry. With deep expertise in value and access strategy\, payer research\, and creating value communication tools\, AESARA crafts compelling evidence-based frameworks\, from early market entry to lifecycle management and launch readiness. Headquartered in Chapel Hill\, NC\, the agency has partnered with leading biopharma companies\, completing over 600 client engagements and supporting more than 50 global product launches. Known for innovation and strategic insight\, AESARA empowers clients with transformative solutions tailored to the evolving healthcare landscape.\nGold Sponsor\nSciensus is a leader in integrated commercial services with 30 years’ experience in navigating the complex European healthcare ecosystem to maximise patient access to medicines\, accelerate product launches and achieve full commercialisation. Through our skilled team of over 500 licensed clinical staff\, we support 300\,000 patients and partner with 4\,000hospitals\, pharmacies and clinics each year.Our services include early access programmes\, non-interventional and decentralised trialsupport\, importation\, warehousing and delivery\, clinical care and IMP logistics\, easing the path from pre-authorisation through to full commercialisation.\nSpeaking Sponsor\nSavana is the global leader in science-level Clinical NLP – delivering multilingual solutions exclusively trained on electronic health records (EHRs). Our comprehensive platform ensures the deepest regulatory-grade Real-World Evidence\, ensuring scientific accuracy\, semantic interoperability\, and privacy by design.Core products include Savana Manager Suite (SMS) for structuring hospital data\, Savana Data Space (SDS) for federated collaboration\, Savana Next Generation Registries (NGRs) for dynamic\, longitudinal insight\, and the Smart Health Alliance (SHA)\, a global network for scalable evidence generation. Savana enables hospitals\, life sciences\, and regulators to unlock value from data\, securely\, ethically\, and with measurable clinical and scientific impact.\nFor Exhibitors & Sponsors\nPlatinum\nGold\nSilver\nBronze\nDigital\nCustomized\nPlatinum\n2 VIP Passes 2 User Passes Premium Logo Positioning 1 Speaker's Slot Wishlist (15 Clients Max.) Exhibition Stand Premium Banner Placing Promotional Insertion Delegate List Your Company Logo Your Company Profile\nGold\n2 VIP Passes2 User PassesPremium Logo Positioning1 Speaker's SlotWishlist (15 Clients Max.)Premium Banner PlacingPromotional InsertionDelegate ListYour Company LogoYour Company Profile\nSilver\n1 VIP Pass1 User PassPremium Logo PositioningExhibition StandPremium Banner PlacingPromotional InsertionDelegate ListYour Company Logo on our Agenda & Website.Your Company Profile\nBronze\n1 VIP Pass.Premium Logo Positioning.Premium Banner Placing.Promotional Insertion.Your Company Logo at Event Agenda & Website.Your 100 words Company Profile at website.\nDigital Partner\nPremium Logo Positioning.Premium Banner Placing.Promotional Insertion.Your Company Logo on Website & Event Agenda.Your Company's 100 words Profile on our Website\nCustomized Solution\nFor Customized Solutions please write to us on "booking@wlcus.com" followed by the Subject.\nRegister Now!\nTickets and Registration\nWLCUS\nGlobal RWE & MarketAccess Summit 2025\nSingle Delegate\n€ 749\n€ 1000\nPremium\nBuy Now\nWLCUS\nGlobal RWE & MarketAccess Summit 2025\nDouble Delegate\n€ 998\n€ 2000\nUpgraded Premium\nBuy Now\nWLCUS\nGlobal RWE & MarketAccess Summit 2025\nSingle Delegate\n€ 1498\n€ 2000\nSolution Provider & Consultants\nBuy Now\nRelated Videos\nDivider\nWhy RWE Can Make or Break Your Drug Launch\nRWE is Revolutionizing the Pharma Industry\nDrone Technology & Data Insights
URL:https://wlcus.com/event/rwe_market_access_summit_2025/
LOCATION:Frankfurt\, Germany
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/7a39c1071aa0f0b95730489d.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260304T110000
DTEND;TZID=UTC:20260304T120000
DTSTAMP:20260305T100957Z
CREATED:20260123T163234Z
LAST-MODIFIED:20260305T100957Z
UID:15591-1772622000-1772625600@wlcus.com
SUMMARY:Next Generation RWE
DESCRIPTION:Next Generation RWE\nAI & Living Evidence Hubs\, The New Generation of RWE\nFree to Attend\nMarch 4th\, 2026\nRegister Now !\nRequest Agenda\nRegister Now\nThe Next Generation Real-World Evidence\nMeet the Keynote\nWe are honored to welcome Dr. Ignacio H. Medrano as our keynote speaker for this session. A consultant neurologist and a visionary entrepreneur\, Dr. Medrano operates at the cutting edge of clinical medicine and artificial intelligence. As the Founder and Chief Medical Officer of Savana\, he spearheads the development of advanced Clinical Natural Language Processing (cNLP) to unlock vital insights from unstructured Electronic Health Records on a global scale. Recognized by Forbes as one of the most creative minds in business and a recipient of the Princess of Girona Award\, Dr. Medrano brings a wealth of expertise from his background at Singularity University. In this keynote\, he will guide us through the evolution of AI-driven research\, providing a roadmap to bridge the gap between raw clinical data and regulatory-grade evidence for 2026.\nFeaturing Knowledge Partner\nSavana is the global leader in science-level Clinical NLP – delivering multilingual solutions exclusively trained on electronic health records (EHRs). Our comprehensive platform ensures the deepest Regulatory-grade Real-World Evidence\, ensuring scientific accuracy\, semantic interoperability\, and privacy by design.Core products include Savana Manager Suite (SMS) for structuring hospital data\, Savana Data Space (SDS) for federated collaboration\, Savana Next Generation Registries (NGRs) for dynamic\, longitudinal insight\, and the Smart Health Alliance (SHA)\, a global network for scalable evidence generation. Savana enables hospitals\, life sciences\, and regulators to unlock value from data\, securely\, ethically\, and with measurable clinical and scientific impact.\nThe Next Generation\, Real-World Evidence\nWho Should Attend\nGlobal Director / Head of Real World Evidence\nGlobal Director / Head of HEOR & Outcomes Research\nGlobal Medical Affairs Leadership\nGlobal Market Access / HEVA Leadership\nEvidence Generation & Evidence Strategy Leads\nMedical Innovation & Digital Evidence Leaders\nClinical Development & Translational Research Leaders\nData Science & Advanced Analytics Leaders (Healthcare)\nAttendee's Benefit\nWhat Attendees will Gain\nMaster cNLP for Evidence Generation\nLearn how to leverage clinical Natural Language Processing (cNLP) to transform unstructured Electronic Health Records into high-quality\, regulatory-grade evidence.\nScale Beyond Traditional Registries\nDiscover how next-generation\, AI-enabled registries overcome the scalability and timeliness limitations of traditional methods to support rapid decision-making.\nNavigate the 2026 Regulatory Landscape\nGain a clear roadmap for meeting the mission-critical RWE requirements set by global regulators and HTA bodies for the 2026–2028 cycle.\nOperationalize Reverse Translational Research\nUnderstand how to turn real-world clinical narratives into actionable research hypotheses\, bridging the gap between clinical practice and development strategy.\nOptimize the Entire Product Lifecycle\nExplore practical AI use cases that add value at every stage\, from pre-launch evidence building to long-term post-market lifecycle management.\nExclusive Collaboration with the RWE Summit\nThis webinar serves as a strategic preview for the European RWE & Market Access Summit\, where you can join industry leaders to master JCA submissions and PICO scoping in person.\nTickets and Registration\nWLCUS\nNext Generation RWE 60 Mins\nLive Webinar\nFree\nAttend Now\nAttend The Live Webinar\nRelated Videos\nDivider\nWhy RWE Can Make or Break Your Drug Launch\nRWE is Revolutionizing the Pharma Industry\nDrone Technology & Data Insights
URL:https://wlcus.com/event/the_next_generation_rwe_live_webinar/
LOCATION:Online
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/5469195efa1cc6f599c2fedf.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260809T090000
DTEND;TZID=UTC:20260809T170000
DTSTAMP:20260809T104846Z
CREATED:20260809T102341Z
LAST-MODIFIED:20260809T104846Z
UID:19034-1786266000-1786294800@wlcus.com
SUMMARY:AI Driven Market Access Masterclass 2027
DESCRIPTION:In-House Training\nAI-Driven Market Access\nMasterclass\nBuilding Trusted Evidence & Securing Payer Agreements\nEnquire Now for Registration\nLead Industry Expert & Masterclass Instructor\nWorld-Class Corporate Leadership\nThis in-house masterclass is led by senior market access strategists\, former HTA advisory panelists\, and AI implementation specialists with 20+ years of global pharmaceutical experience.\nProven Track Record: Former commercial strategy executives who have led cross-border pricing\, reimbursement\, and HTAR readiness programs across the EU\, UK\, and US markets.Technical & Academic Authority: Guest lecturers and advisors to top European business schools\, with extensive background in structured financial models\, RWE integration\, and health economics.Practitioner-Led Instruction: Real-world practitioners who actively consult multi-lateral healthcare bodies and global pharma syndicates\, ensuring your team learns field-tested frameworks\, not just theory.Official lead trainer bio\, full profile\, and keynote background will be announced upon custom workshop scheduling.\nThis masterclass is designed for cross-functional professionals and leaders working in:Pharmaceutical & Biotech Companies: Market Access\, HEOR\, RWE\, Pricing & Reimbursement\, Regulatory Affairs\, Medical AffairsMedTech & Diagnostics Firms: Evidence Generation\, Payer Value & AccessHealthcare Solution Providers & Consultancies: AI\, HEOR\, Data Analytics\, Market Access ServicesPayers & HTA Agencies: Professionals seeking to understand industry AI adoption\nHead / Director / Manager of Market Access\nHEOR / HTA / Pricing & Reimbursement Leads\nRWE / Data Science / Medical Affairs Leads\nStrategy & Policy Professionals in Market Access\nRecognized Enterprise & Individual Certification\nInvest in certified excellence. Upon successful completion of the AI-Driven Market Access Masterclass\, both your individual team members and your enterprise receive official recognition validating your operational readiness and compliance standards.1. Individual Certification of CompletionEvery participating team member will be awarded an official WLCUS Completion Certificate in AI-Driven Market Access.Skill Validation: Formally credentials advanced mastery in RWE generation\, automated SLR platforms\, digital twin health economic modeling\, and AI-assisted payer negotiations.Professional Distinction: Demonstrates cross-functional expertise across Market Access\, HEOR\, RWE\, and Regulatory Affairs.2. Enterprise Compliance & Capability BadgeYour organization will be issued the WLCUS Corporate AI Market Access & HTAR Readiness Compliance Seal.Audit-Ready Validation: Serves as official documentation that your cross-functional teams have undergone structured\, compliant training aligned with EU AI Act\, GDPR\, and HTAR joint clinical assessment standards.Payer & Stakeholder Trust: Demonstrates to global payers\, regulatory authorities\, and industry partners that your enterprise deploys governance-first\, audit-tested AI methodologies in evidence generation and dossier preparation.Corporate Distinction: Positions your company as a forward-thinking\, fully equipped leader in AI-enabled pharmaceutical commercialization.\nRegister Now!\nRelated Videos\nDivider\nHSE Nexus & Expo 2025 is coming to Berlin\nThe Rise of EHS Solutions\nDrone Technology & Data Insights
URL:https://wlcus.com/event/ai-driven-market-access-masterclass/
LOCATION:Online
CATEGORIES:In-house Training,Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/7f3120373b139978d7e99a26.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20261021T080000
DTEND;TZID=UTC:20261022T170000
DTSTAMP:20261103T094034Z
CREATED:20251116T140429Z
LAST-MODIFIED:20261103T094034Z
UID:15028-1792569600-1792688400@wlcus.com
SUMMARY:European RWE & Market Access Summit 2026
DESCRIPTION:European RWE & Market AccessSummit 2026\nJCA & PICO Strategy Edition\nOctober 21-22  |  Amsterdam\nInntel Hotels Amsterdam Landmark\nRequest Agenda\nRegister Now\nRegister Now !\nRequest Agenda\nRegister Now\n2026 Strategic Focus\nWhy This Summit is the Industry’s Definitive "Don’t-Miss" Briefing\nJCA Submission Mastery\nNavigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the "how-to" on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window.\nPICO Scoping & Strategy\nEliminate "PICO anxiety" by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process.\nDARWIN EU 2.0 Operations\nGet a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate "regulatory-grade" evidence that meets the highest standards of data quality and scientific integrity for 2026–2028.\nNational HTA Alignment\nSolve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles.\nAI-Driven Evidence Synthesis\nExplore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the "data-to-submission" lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments.\nPayer & Regulator Networking\nBreak down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline.\nJoin the Summit on October 21-22 in Amsterdam\, Netherlands\nPharmaceutical Companies\nBio-Pharma Companies\nRWE / HEOR Directors & Leads\nMarket Access Directors & Senior Managers\nPricing & Reimbursement Leaders\nMedical Affairs\nEvidence Strategy Teams\nRegulatory Strategy Teams\nHTA Assessors\nReal World Data - RWD\nReal World Evidence - RWE\nPayer Decision Makers\nPolicy Makers\nEvidence Reviewers\nAI in HealthCare Experts\nRWD Platform Providers\nDigital Therapeutics Companies\nFederated Data Networks\nEvidence Technology Innovators\nHEOR Modelling Experts\nEvidence Specialists\nHealth Economists\nAccess Researchers\nOur RWE & Pricing Event 2026\, Stats:\nSpeakers\nProfessionals & Leaders\nCountries\nMeet the Conference Speakers & Thought Leaders\nOur Prestigious Panel of Speakers\nThe Chair\nDr. Vivian Mendonca\nSVP- Global Head - Commercial\nStrategy\, Access\, Pricing\, HEOR\,\nCDx\, Policy and Patient\nEngagement\nMENARINI Group\nElena Petelos\nVice President \nHealth Technology Assessment\nEuropean Public Health Association\nCharlotte Litrowski\nHead of Market Access & Pricing  EMEA / RoW\nSERB Pharmaceuticals\nDr. Magda Chatzikou\nHTA & RWE Strategist ofDigital Health\nPharmaecons Easy Access\nDr. Marco Penske\nHead of Market Access &  Healthcare Affairs\nBoehringer Ingelheim\nYvette Venable\nHead of EUCAN Market Access\nAstraZeneca\nDiana Sinkevich\nVP\, Access and Global HEOR \nGlobal Rare Diseases\nChiesi Group\nDr. Natalie Steck\nInternational HTA Strategy\n& Policy Director\nMSD\nCatia Proenca\nEU-HTADirector\nBayer\nAnke Sieg\nHead of JCA  HTA\n& Payer\nU C B\nFabian Schmidt\nGlobal Head of Value & Access  and Policy\nRecordati Rare Disease\nDr. Sofie Gustafsson\nGlobal Director\, RWE Partnerships & Innovation (Intl. Markets)\nPfizer\nHélène Karcher\nEvidence Solution Leader\nROCHE\nCarolin Knorr-Hendreich\nPrincipal Consultant  HTA\n& Market Access\nDLRC Group\nRonald Vollebregt\nReal World Data  Manager\nAMGEN\nDr. Katrin Kupas\nSr. Director\, Head of\nRWE Oncology\nMerck Healthcare\nDr. Burçak Aydın\nDirector\, Deloitte Strategy Value & Access Team\nDeloitte\nDr. Debarshi Dey\, PhD.\nVice PresidentHead of Data Science\nLakefront\nStefano Marino\nFormer head of  Legal Department\nEx - E M A\nRosemary Jose Haaksman\nFounder  & Consultant\nBridges2Access\nAndrea Bilgeri\nHead of Value and Access Specialty Medicine Europe\nDaiichi Sankyo\nLora Fleifel\nMarket Access and Pricing Operations Director- Specialty care and Rare Tumors- Europe\nMerck Healthcare\nDr. Deepti Tayal\nChief Executive Officer  CEO\nIngenious e-Brain Solutions\nFelix Steinbrenner\nCo-Founder  Co-CEO\nCellbyte\nErik Alferink\nDirector\, Health Economics\, Market\nAccess\, and Reimbursement\n(HEMAR) Hospital Patient Monitoring\nPhilips\nNandia Gogozotou\nPresident of the Innovation Fund\nCommittee & President of the Drug\nPrice Negotiation Committee\nGreek MInistry of Health\nMounia Chabane\nCo-Founder and Global Head  Research & Development\nI A R O D\nRavi Jandhyala\nConsultant Pharmaceutical Physician\nMedialis Ltd.\nJoin the EU moment Now!\nEvent 2026 Sponsors\, Exhibitors & Partners\nDLRC Group\nCellbyte\nIngenious e-Brain\nVelora Evidence\nBridge2Access\nDLRC Group is a leading life sciences consultancy specializing in Regulatory Affairs\, HTA\, and Market Access strategy for pharmaceutical\, biotechnology\, medical device\, and healthcare companies. With offices in the UK\, Germany\, and the US\, DLRC supports organizations from early development through commercialization and lifecycle management. Their expertise includes regulatory strategy\, evidence planning\, HTA submissions\, reimbursement pathways\, payer engagement\, and market access optimization. DLRC helps clients navigate complex global regulatory and access requirements\, ensuring products reach patients efficiently. Their strong focus on evidence generation\, HTA readiness\, and market access makes them highly relevant to organizations operating within the evolving EU-HTA and Real- World Evidence landscape.\nCellbyte is an AI-native platform helping pharmaceutical companies accelerate global drug launches by transforming complex pricing\, market access\, HTA\, regulatory\, and clinical data into actionable insights. Its intelligent AI agents automate time-consuming workflows\, enabling faster\, more informed decision-making across the product commercialization lifecycle. Trusted by leading pharmaceutical organizations\, Cellbyte empowers Market Access\, HEOR\, Pricing\, and Commercial teams to streamline launch planning\, optimize reimbursement strategies\, and improve cross-functional collaboration. By combining advanced AI with comprehensive\, continuously updated global healthcare data\, Cellbyte enables organizations to reduce manual effort\, enhance strategic planning\, and bring innovative therapies to patients faster across international markets\nIngenious e-Brain Solutions (IEBS) is a global management consulting and intelligence firm with 14+ years of experience supporting leading life sciences and healthcare organizations. We help clients navigate complex RWE\, market access\, HEOR\, HTA\, pricing & reimbursement\, and JCA challenges through deep domain expertise\, advanced analytics\, AI\, and technology. With 5\,000+ engagements and partnerships with 50+ Fortune 500 and Global 2000 organizations\, we combine proven expertise with agile\, scalable delivery. As market access evolves towardfaster evidence generation and more integrated HTA frameworks\, IEBS is transforming its heritage into velocity-using AI\, automation\, and advanced analytics to accelerate insights\, strengthen evidence strategies\, and enable faster\, smarter patient access.\nVelora Evidence is an evidence generation and medical affairs consultancy. We build integrated evidence generation plans through facilitated workshops\, and support the execution of the real-world studies that follow\, whether observational\, registry based\, patient reported\, or drawn from claims and linked health data. We provide strategic and operational oversight from design and protocol through to analysis and publication strategy.\nBridges2Access partners with pharmaceutical\, biotechnology\, and medical technology companies to accelerate patient access through expert support in Market Access\, HEOR\, HTA\, Evidence Generation\, Pricing & Reimbursement\, and Health Policy. With flexible senior-level consulting\, they help organizations develop evidence-based strategies that strengthen value\, support payer engagement\, and improve commercial success.\nRegister Now!\nTickets & Registration\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\n2 + 1 Delegates\n€ 1199\n€ 1999\nBuy Now\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 599\n€ 999\nBuy Now\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 1499\n€ 1999\nBuy Now\nIncluded Accommodation\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 1499\n€ 1999\nBuy Now\nConsultants & Solution Providers\nRelated Videos\nDivider\nWhy RWE Can Make or Break Your Drug Launch\nRWE is Revolutionizing the Pharma Industry\nDrone Technology & Data Insights
URL:https://wlcus.com/event/rwe_market_access_event_2026/
LOCATION:Amsterdam\, Amsterdam\, Netherlands
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/dad45d7bb9ec78959b5044f3.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
END:VCALENDAR